SLDB
Solid Biosciences
$7.89
+$0.06 (+0.77%)Jul 27, 2026
Key metrics
The numbers that frame SLDB today
- Market cap
- $776.77M
- P/E (TTM)
- -4.1
- EV / FCF
- -2.9
- ROIC
- -120.7%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $3.79
- 52wk High
- $11.45
Growth
Revenue and earnings trend for SLDB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SLDB
Is Solid Biosciences a good buy?
Hold. Solid Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Solid Biosciences is selling at a very high price.
What is the market capitalization of SLDB?
Solid Biosciences's market capitalization is $776.77M.
What is the P/E ratio for SLDB stock?
Solid Biosciences's current P/E ratio is -4.1.
What is the 52-week high for SLDB stock?
The 52-week high for Solid Biosciences is $11.45. The current close of $7.89 is 31.1% below that high.
What is the 52-week low for SLDB stock?
The 52-week low for Solid Biosciences is $3.79. The current close of $7.89 is 108.2% above that low.
Does SLDB stock pay dividends?
Solid Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SLDB?
Solid Biosciences's Debt / Equity ratio is 0.06.